See what happens when hyperacute T-waves are missed

Written by Pendell Meyers, edits by Steve Smith

A man in his 60s with history of hypertension and MI 10 years ago, with PCI, presented to an outside hospital complaining of chest pain that started while mowing the lawn. His chest pain was located in the central chest, non-radiating, and associated with diaphoresis, nausea, and vomiting.

Here is his ECG on arrival:

What do you think?

This ECG is all but diagnostic of subepicardial ischemia of the anterior, lateral, and inferior walls, most likely due to Occlusion MI (OMI), probably of the LAD. This is evidenced by hyperacute T-waves in leads V3-V6. Leads II and aVF also have hyperacute T-waves. The R-wave progression is extremely poor which is also common in large anterolateral Occlusion MI (OMI). There is a very small amount of STE in some of the anterior, lateral, and inferior leads which do NOT meet STEMI criteria.

This ECG is highly suspicious for LAD OMI. If you have any doubts, you should record another one every 5 minutes until you are convinced.

The most likely location for an occlusion producing OMI changes in the anterolateral and inferior leads is the proximal-to-mid LAD. Usually this will be either a type II LAD (which supplies the apex) or a type III LAD (which goes even further and curves around the apex to the inferior aspect of the apex).

Remember that the ECG reports what is happening to the myocytes, then you must use that information to make inferences about what the patient needs. Acute coronary occlusion is the most common and most treatable cause of this pattern, but it is not the only cause. The myocytes do not know why they are dying, they can only report their death and hope you can see it and figure it out. Takotsubo, spasm, low flow with a preexisting stable coronary lesion, etc. are other causes of acute focal myocyte death which produce the same ECG findings.

This patient clearly needs emergent angiography and reperfusion of the LAD lesion that is causing his Occlusion MI until proven otherwise. 

Here is his prior ECG on file from the outside hospital from long ago:

This ECG from years ago shows anterolateral OMI with signs of prolonged/subacute MI (QS waves, poor anterior R wave progression) but also reperfusion including terminal T-wave inversions in V1-V5. One must always be careful when looking for “baseline” ECGs, because the prior ECG on file may have been during another ACS event, as this one clearly was. This ECG was presumably performed during the patient’s prior MI, most likely during a period of reperfusion or after PCI of the LAD (this information is not available). 
This ECG can never be a baseline ECG. If subsequent ECGs were available, they would have shown resolution of these reperfusion T-waves over days to weeks. In such a case, the presentation ECG would not represent pseudonormalization (because the ECG would have returned to baseline). However, if this ECG had been recorded within the previous week, then the presentation ECG would indeed be indicative of pseudonormalization (reocclusion during an ACS event causing reperfusion T-wave inversions to re-inflate and turn positive, or “pseudonormal”).

The EM physicians at the outside hospital activated the cath lab transfer protocol (unless cardiology cancels the activation, our cath lab is activated, and the patient is transferred immediately from the outside hospital to our cath lab).

The case was reviewed by all parties, and it was stated correctly that the ECG does not meet the STEMI criteria.

Cath lab activation was cancelled but the transfer was accepted for urgent cardiology evaluation.

40 minutes after the first ECG, just before transport, a repeat ECG was obtained:

Continued, active OMI of the anterior, lateral, and inferior walls.

In the ambulance during transport, the patient suddenly suffered VF arrest.

He was defibrillated immediately and had return of normal mental status.

Upon arrival, providers again reviewed the ECGs and found no reason on ECG for emergent catheterization. Given the VF arrest during transport, however, they appropriately all agreed that cath should happen sooner rather than later.

They took him almost immediately for catheterization. They found an acute lesion of the LAD at the site of the prior stents, including 70% proximal LAD lesion and 95% mid-LAD stenosis with TIMI 3 flow at the time of cath. There was also a chronic total occlusion of the RCA. The LAD lesion was acute and required 3 stents to restore flow. Here are the images of the acute LAD lesion:

The mid-LAD is nearly occluded, but with distal flow. 
In this view it appears to be a total occlusion, however the video shows delayed slow flow through the LAD lesion.



Troponin T peaked at 3.86 ng/mL (very high).

Echo the next day showed EF 35% with wall motion abnormalities of the mid-anterolateral, mid-anterior, mid-inferior, mid-inferolateral, mid-inferior, mid-anterior septum, mid-inferior septum, anterior apex, lateral apex, inferior apex, septal apex, and the apical cap. This distribution matches the distribution of OMI findings on ECG (although some of the WMA could be explained by the previous Q-wave infarct in the prior ECG).

Here are his repeat ECGs after intervention:

This shows new Q-waves in V4-V6, with persistent STE and positive T-waves in the anterolateral leads which matches left ventricular aneurysm morphology. These findings are consistent with full thickness infarction. In Dr. Smith’s experience one must wait at least 2 weeks to find out if this electrical LVA morphology will resolve, and whether it will be accompanied by anatomic aneurysm.

Similar findings.

Learning Points:

Patients deserve to have their Occlusion MI recognized prior to (or even in the total absence of) STEMI criteria.

Expert ECG interpretation could have prevented this man’s cardiac arrest, and almost certainly would have resulted in a much smaller MI and therefore better long term prognosis.

The STEMI vs. NSTEMI paradigm is not the best way to decide who needs emergent reperfusion therapy. The most recent available RCT evidence (the FTT Meta-analysis published in 1994) would suggest that this patient receives mortality harm from emergent reperfusion therapy (thrombolytics), because his ECG does not meet STEMI criteria (see diagrams below representing the mortality effects of thrombolytics from the FTT meta-analysis). This is obviously false, and this demonstrates how the STEMI vs. NSTEMI paradigm has brainwashed us into failing to recognize other ECG findings which predict Occlusion MI. In the FTT meta-analysis there was no expert ECG interpretation, there was simply an undefined trichotomous classification of “ST elevation,” “ST depression”, or “normal” ECG. Additionally the studies in the FTT meta-analysis were done in an era without cardiac catheterization, and thus they were unable to distinguish between occlusions and non-occlusions among those without ST elevation. For more, see The OMI Manifesto.

Powered by WPeMatico